• On the basis of the community epidemiology of mumps, most people born in Canada before 1970 are immune to mumps -likely exposed to the wild mumps virus that was circulating during their childhood • In August 2007, NACI issued a revised statement for mumps-containing vaccine -two-dose mumps immunization is now recommended for infants and children, as well as certain adult high-risk groups -consideration of a single dose of MMR vaccine for high-risk adults (e.g. health care workers) born before 1970 -All provinces and territories now offer two dose schedule 13 Canadian cohorts offered one dose of mumpscontaining vaccine by jurisdiction and birth year 1950 1955 1960 1965 1970 1975 1980 1985 1990 1995 i. mumps virus detection or isolation from an appropriate specimen (buccal swab is preferred); ii. positive serologic test for mumps IgM antibody in a person who has mumps-compatible clinical illness iii. significant rise (four-fold or greater) or seroconversion in mumps IgG titre; iv. mumps-compatible clinical illness, in a person with an epidemiologic link to a laboratory-confirmed case. 16 Clinicial/Probable Case Definition • Acute onset of unilateral or bilateral parotitis lasting longer than 2 days without other apparent cause 17
Contact Definition
Any of the following during the infectious period (i.e. approximately 7 days before to 5 days after symptom onset): i. household contacts of a case; ii. persons who share sleeping arrangements with the case, including shared rooms (e.g. dormitories); iii. direct contact with the oral/nasal secretions of a case (e.g. face-to-face contact, sharing cigarettes/drinking glasses/food/cosmetics like lip gloss, kissing on the mouth); iv. children and staff in child care and school facilities. 18 
Laboratories
• RT-PCR is reliable for the definitive diagnosis of an acute mumps infection, but its sensitivity can be influenced by the following:
-timing of the specimen collection in relation to onset of illness; -specimen integrity (rapid specimen processing).
• Buccal swab or saliva from the buccal cavity collected within the first 3 to 5 days of parotitis or symptom onset is the preferred specimen • Testing for mumps-specific IgM class antibody has been shown to be poorly predictive for the diagnosis of acute mumps in a partially immunized population (may only be detectable in 30% of acute cases). 19 
Case Management
Clinical cases should be managed as confirmed cases until laboratory evidence suggests otherwise 1. Mumps is a reportable disease in all Canadian jurisdictions, and public health authorities should be notified through the usual channels. 2. In the absence of an epidemiologic link to a confirmed case, an oral swab (buccal specimen is preferred) should be obtained for laboratory confirmation. 3. Assess risk factors: obtain immunization and/or disease history, assess epidemiologic links to cases or settings, including travel.
4. There is no specific treatment for mumps, only supportive care. Health care providers can offer second dose of mumps vaccine if patient has only received one previously.
5. Advise the case to: a. stay home (self-isolate) for 5 days from symptom onset b. wash or sanitize their hands often c. avoid sharing drinking glasses, eating utensils or any object used on the nose or mouth d. cover coughs and sneezes with a tissue or forearm
